Detalhe da pesquisa
1.
Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes.
Oncologist
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417095
2.
Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA.
Future Oncol
; 19(20): 1397-1414, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318757
3.
Clinical outcomes and toxicities of pazopanib administered orally in crushed form: Case reports and review of the literature.
J Oncol Pharm Pract
; 26(1): 232-235, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30961437
4.
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(12): 1529-1554, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31805523
5.
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 18(3): 312-322, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28131785
6.
Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen.
Mol Ther
; 22(11): 1910-22, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24954476
7.
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810.
J Clin Oncol
; : JCO2301544, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531002
8.
Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group.
Cancer
; 119(11): 1994-8, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23456777
9.
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).
J Clin Oncol
; 40(28): 3301-3309, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35446628
10.
Comprehensive review of chromophobe renal cell carcinoma.
Crit Rev Oncol Hematol
; 160: 103287, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753250
11.
Predicted Immunogenicity of CDK12 Biallelic Loss-of-Function Tumors Varies across Cancer Types.
J Mol Diagn
; 23(12): 1761-1773, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562615
12.
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance).
J Clin Oncol
; 39(22): 2486-2496, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989025
13.
Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216).
Clin Cancer Res
; 27(7): 1967-1973, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33500355
14.
Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting.
J Pers Med
; 10(4)2020 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33260805
15.
Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma.
Clin Cancer Res
; 26(10): 2327-2336, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034074
16.
Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial.
J Clin Oncol
; 36(8): 765-772, 2018 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29309249
17.
Individualization of Adjuvant Therapy After Radical Prostatectomy for Clinically Localized Prostate Cancer: Current Status and Future Directions.
Clin Genitourin Cancer
; 14(1): 12-21, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341039
18.
Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables.
J Clin Oncol
; 21(22): 4100-4, 2003 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14615439
19.
Immunotherapy in Metastatic Renal Cell Carcinoma: A Comprehensive Review.
Biomed Res Int
; 2015: 367354, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26161397
20.
Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study.
Leuk Res
; 28(1): 49-52, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14630080